A device specifically intended to benefit patients with a disease or condition presenting in no more than 12,000 individuals in the EU per year, where there is an insufficiency of available alternatives or where clinical data cannot reasonably be generated in the usual way. A guidance concept affecting the clinical evidence expected.
Reference: MDCG 2024-10